SynthesisEuropean journal of cancer (Oxford, England : 1990)2012

Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.

Jiangbo Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.